Format

Send to

Choose Destination
Chem Biodivers. 2010 May;7(5):1026-39. doi: 10.1002/cbdv.200900323.

A genome-scale metabolic model of Cryptosporidium hominis.

Author information

1
Center for the Study of Biological Complexity, VCU Life Sciences, Virginia Commonwealth University, P.O. Box 980678, 1101 E. Marshall St., 5-036 Sanger Hall, Richmond, VA 23298-0678, USA.

Abstract

The apicomplexan Cryptosporidium is a protozoan parasite of humans and other mammals. Cryptosporidium species cause acute gastroenteritis and diarrheal disease in healthy humans and animals, and cause life-threatening infection in immunocompromised individuals such as people with AIDS. The parasite has a one-host life cycle and commonly invades intestinal epithelial cells. The current genome annotation of C. hominis, the most serious human pathogen, predicts 3884 genes of which ca. 1581 have predicted functional annotations. Using a combination of bioinformatics analysis, biochemical evidence, and high-throughput data, we have constructed a genome-scale metabolic model of C. hominis. The model is comprised of 213 gene-associated enzymes involved in 540 reactions among the major metabolic pathways and provides a link between the genotype and the phenotype of the organism, making it possible to study and predict behavior based upon genome content. This model was also used to analyze the two life stages of the parasite by integrating the stage-specific proteomic data for oocyst and sporozoite stages. Overall, this model provides a computational framework to systematically study and analyze various functional behaviors of C. hominis with respect to its life cycle and pathogenicity.

PMID:
20491062
DOI:
10.1002/cbdv.200900323
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center